Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)

Translated title of the contribution: Comparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)
  • S.H. Lowe
  • , A.M.J. Wensing
  • , E.A. Hassink
  • , R.W. ten Kate
  • , C. Richer
  • , G. Schreij
  • , P.P. Koopmans
  • , J.R. Juttmann
  • , I. van der Tweel
  • , J.M.A. Lange
  • , J.C.C. Borleffs

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionComparison of two once-daily regimen Consisting of nelfinavir, didanosine and stavudine in antiretroviral therapy-naïve adults: 48-week results from the antiretroviral evaluation study (ARES)
Original languageUndefined/Unknown
Pages (from-to)235-245
Number of pages11
JournalHIV Clinical Trials
Volume6
Issue number5
Publication statusPublished - 2005

Cite this